SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Value Creation Plan Crystallises

7 Jan 2013 07:00

RNS Number : 9097U
Gooch & Housego PLC
07 January 2013
 



For immediate release

7 January 2013

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Value Creation Plan Crystallises

 

 

Gooch & Housego PLC, the specialist manufacturer of optical components & systems, announces that the Company's Value Creation Plan (VCP) crystallises today.

 

Further to the update issued on 4 October 2012, we are now able to provide details of the share option awards and share awards that will be made today. As a reminder, on 7 January 2010, following consultation with major shareholders, a share-based incentive scheme in the form of a VCP was put in place. At the same time approved share options were awarded under the Company Share Option Plan (CSOP) to UK-based participants. In accordance with the rules of the plan, on the third anniversary of the plan (today) the value created during the life of the plan, over and above a pre-determined threshold value based on a share price of £2.00, has been calculated and a share of that value (approximately 12%) will be distributed among the participating members of the senior management of the Company in the form of nil-cost share options (UK participants) and share awards (US participants). Half of the awards made today are exercisable immediately and the balance after twelve months, subject to certain conditions.

 

Details of the awards are as follows: -

 

Total number of market value CSOP share options awarded: 158,936

Total number of nil-cost share options and shares awarded: 1,380,566

 

In terms of dilutive effect, in aggregate these awards amount to 7% of the current issued share capital, although, as mentioned above, half the awards are not exercisable for twelve months.

 

Aggregate awards made to directors of the Company are as follows: -

 

Gareth Jones (CEO): 19,867 CSOP share options

450,747 Nil-cost share options

 

Terry Scribbins (COO) 19,867 CSOP share options

265,296 Nil-cost share options

 

Andrew Boteler (CFO) 19,867 CSOP share options

265,296 Nil-cost share options

 

Save for possibly some of the CSOP share options, the above directors are not planning to exercise any of their nil-cost options until June 2013 at the earliest.

 

For further information contact: -

 

Gareth Jones / Andrew Boteler

Gooch & Housego plc

01460 256440

Tim Thompson / Nicola Cronk

Buchanan

020 7466 5000

Patrick Robb/James Grace

Investec Bank plc

020 7597 5970

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNVUROAAARAR
Date   Source Headline
15th Aug 20242:05 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSTrading Update
7th Aug 20248:48 amRNSDirector/PDMR Shareholding
31st Jul 202411:34 amRNSHolding(s) in Company
30th Jul 202412:17 pmRNSHolding(s) in Company
29th Jul 20248:56 amRNSHolding(s) in Company
11th Jun 202412:57 pmRNSNotification of Major Holdings
4th Jun 20242:06 pmRNSDirector/PDMR Shareholding
4th Jun 20247:00 amRNSInterim Results
31st May 20249:05 amRNSBoard Changes
13th May 20247:00 amRNSNotification of Half Year Results
4th Apr 20247:00 amRNSHalf Year Trading Update
18th Mar 20242:36 pmRNSDivestment of EM4
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20243:26 pmRNSNotification of Major Holdings
22nd Feb 20244:07 pmRNSNotification of Major Holdings
21st Feb 202412:31 pmRNSResult of AGM
21st Feb 202410:28 amRNSDirector/PDMR Shareholding
21st Feb 20249:43 amRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSAGM Trading Update
12th Jan 20247:00 amRNSAnnual Report and Notice of AGM
10th Jan 20247:00 amRNSGrant of LTIP Awards
9th Jan 202411:53 amRNSNotification of Major Holdings
8th Jan 20243:57 pmRNSNotification of Major Holdings
4th Jan 20243:20 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSResults for the year ended 30 September 2023
8th Nov 20237:00 amRNSNotification of Full Year Results
23rd Oct 20232:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSFull Year Trading Update
2nd Oct 20232:44 pmRNSHolding(s) in Company
9th Aug 20236:15 pmRNSDirector/PDMR Shareholding
31st Jul 20238:22 amRNSHolding(s) in Company
21st Jul 202311:58 amRNSCompletion of Acquisition and Issue of Equity
19th Jul 20237:00 amRNSAcquisition of Artemis Optical
23rd Jun 20234:11 pmRNSHolding(s) in Company
21st Jun 202310:26 amRNSDirector/PDMR Shareholding
20th Jun 20236:00 pmRNSAcquisition of GS Optics
6th Jun 20237:00 amRNSInterim Results
23rd May 20237:00 amRNSNotification of Half Year Results
3rd May 20238:56 amRNSIssue of Equity
4th Apr 20237:00 amRNSHalf Year Trading Update
30th Mar 20239:33 amRNSHolding(s) in Company
15th Mar 202312:00 pmRNSAppointment of Non-Executive Director
3rd Mar 20234:37 pmRNSHolding(s) in Company
2nd Mar 20231:10 pmRNSHolding(s) in Company
1st Mar 20239:44 amRNSHolding(s) in Company
22nd Feb 20231:50 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Trading Update
8th Feb 202312:59 pmRNSHolding(s) in Company
9th Jan 202311:44 amRNSGrant of LTIP Awards

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.